Ozempic’s new frontier: The war on aging
The Wall Street Journal: Rong Xu, director of the Center for Artificial Intelligence in Drug Discovery, discussed her study on semaglutide and Alzheimer’s disease and how the drug's strength lies in the different ways it functions. “It’s like one stone, multiple birds,” she said.
